Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study

Michela Antonelli, Rose S Penfold, Jordi Merino, View ORCID ProfileCarole H Sudre, Erika Molteni, Sarah Berry, Liane S Canas, View ORCID ProfileMark S Graham, Kerstin Klaser, Marc Modat, Benjamin Murray, Marc F Österdahl, Nathan J Cheetham, David Drew, View ORCID ProfileLong Nguyen, Joan Capdeila Pujol, Christina Hu, Somesh Selvachandran, Lorenzo Polidori, Anna May, Jonathan Wolf, Andrew T Chan, Alexander Hammers, Emma Duncan, Tim D Spector, View ORCID ProfileSebastien Ourselin, Claire J Steves
doi: https://doi.org/10.1101/2021.05.24.21257738
Michela Antonelli
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rose S Penfold
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
3Department of Ageing and Health, Guys and St Thomas’ NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Merino
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
5Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
6Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carole H Sudre
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
7MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK
8Centre for Medical Image Computing, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carole H Sudre
Erika Molteni
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Berry
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liane S Canas
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark S Graham
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark S Graham
Kerstin Klaser
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Modat
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Murray
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc F Österdahl
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
3Department of Ageing and Health, Guys and St Thomas’ NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan J Cheetham
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Drew
6Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Long Nguyen
6Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Long Nguyen
Joan Capdeila Pujol
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Hu
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Somesh Selvachandran
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Polidori
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna May
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Wolf
9Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew T Chan
10Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hammers
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
11King’s College London & Guy’s and St Thomas’ PET Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Duncan
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim D Spector
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Ourselin
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastien Ourselin
Claire J Steves
2Department of Twin Research and Genetic Epidemiology, King’s College London, UK
3Department of Ageing and Health, Guys and St Thomas’ NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: claire.j.steves@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Both BNT162b2 and ChAdOx1 vaccines show good efficacy in clinical trials and real-world data. However, some still contract SARS-CoV-2 post-vaccination. This study identifies risk factors associated with SARS-CoV-2 infection at least 14 days after first vaccination and describes characteristics of post-vaccination illness.

Methods Cases were UK adults reporting post-vaccination SARS-CoV-2 infection between 8th December 2020 and 1st May 2021, reporting on the COVID Symptom Study app. We assessed the associations of age, frailty, comorbidity, area-level deprivation and lifestyle factors with infection (vaccinated cases vs. negative-vaccinated controls); and vaccination with illness profile (vaccinated cases vs positive-unvaccinated controls).

Findings Post-vaccination infection risk was substantially higher in older adults with frailty (OR= 2.78, 95% CI [1.98-3.89], p-value<0.0001) and in individuals living in most deprived areas (OR vs. intermediate group=1.22, 95%CI [1.04-1.43], p-value=0.01). Risk was lower in individuals with a healthier diet (OR=0.73, 95%CI [0.62-0.86], p-value<0.0001) and without obesity (OR=0.6, 95% CI [0.44-0.82], p-value=0.001). Vaccination was associated with reduced odds of hospitalisation (OR=0.36, 95%CI [0.28-0.46], p-value<0.0001), and high acute-symptom burden (OR=0.51, 95%CI [0.42-0.61], p-value<0.0001). In the 60+ age group, risk of >28 days illness was lower following vaccination (OR=0.72, 95%CI [0.51-1.00], p-value=0.05). Most symptoms were reported less in positive-vaccinated vs. positive-unvaccinated individuals, except sneezing, which was more common post-vaccination (OR=1.24, 95%CI [1.05-1.46], p-value=0.01).

Interpretation Our findings highlight reduced symptom burden and duration in those infected post-vaccination. Whilst reassuring, our data should prompt efforts to boost vaccine effectiveness in at-risk populations; moreover, targeted infection control measures will still be appropriate to minimise SARS-CoV-2 infection.

Funding This work is supported by UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre (BRC) award to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust and via a grant to ZOE Global; the Wellcome Engineering and Physical Sciences Research Council (EPSRC) Centre for Medical Engineering at King’s College London (WT 203148/Z/16/Z). Investigators also received support from the Chronic Disease Research Foundation, the Medical Research Council (MRC), British Heart Foundation, the UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare, the Wellcome Flagship Programme (WT213038/Z/18/Z and Alzheimer’s Society (AS-JF-17-011), and the Massachusetts Consortium on Pathogen Readiness (MassCPR).

Evidence before this study To identify existing evidence for COVID-19 infection post-vaccination, we searched PubMed for peer-reviewed articles published between December 1, 2020 and May 18, 2021 using keywords (“COVID-19” OR “SARS-CoV-2”) AND (“Vaccine” OR “vaccination”) AND (“infection”) AND (“risk factor*” OR “characteristic*”). We did not restrict our search by language or type of publication. Of 202 articles identified, we found no original studies on individual risk and protective factors for COVID-19 infection following vaccination nor on nature and duration of symptoms in vaccinated, community-based individuals. Social and occupational factors influence risk of COVID-19 exposure and infection and personal factors (age, male sex, multiple morbidities and frailty) increased risk for adverse outcomes in COVID-19 in unvaccinated populations. Phase III clinical trials have demonstrated good efficacy of BNT162b2 and ChAdOx1 vaccines against SARS-CoV-2 infection, confirmed in real-world data, which additionally showed reduced risk of adverse outcomes including hospitalisation and death.

Added value of this study This is the first observational study investigating characteristics of and factors associated with SARS-CoV-2 infection after COVID-19 vaccination. We found that vaccinated individuals with frailty had higher rates of infection after vaccination than those without. Adverse determinants of health (e.g. increased social deprivation, obesity or unhealthy lifestyle factors such as less healthy diet) were associated with higher likelihood of infection after vaccination. In comparison with unvaccinated individuals, individuals infected after vaccination had fewer symptoms of COVID-19, and more people were entirely asymptomatic. Fewer vaccinated individuals experienced five or more symptoms, required hospitalisation, and, in the older adult group, fewer had prolonged illness duration (symptoms lasting longer than 28 days).

Implications of all the available evidence Some individuals still contract COVID-19 after vaccination and our data suggest that frail older adults and those living in more deprived areas are more at risk. However, in most individuals illness appears less severe, with reduced need for hospitalisation and less risk of prolonged illness duration. Our results are relevant for health policy post-vaccination and highlight the need to prioritise those most at risk, whilst also emphasising the balance between the importance of ongoing personal protective measures versus adverse effects from ongoing social restrictions. Strategies such as timely prioritisation of booster vaccination and optimised infection control could be considered for at-risk groups. Research is also needed on how to enhance the immune response to vaccination in those at higher risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funders did not have any role in design, analysis or interpretation of the data. Zoe Global, funded by DHSC, made the app available for data collection as a not-for-profit endeavour.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All app users provided informed consent for use of their data for COVID19 research. In the UK, the app and study were approved by Kings College London (KCL) ethics committee (REMAS no. 18210, review reference LRS-19/20-18210).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used in this study are available to bona fide researchers through UK Health Data Research at https://web.www.healthdatagateway.org/dataset/fddcb382-3051- 4394-8436-b92295f14259/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 26, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose S Penfold, Jordi Merino, Carole H Sudre, Erika Molteni, Sarah Berry, Liane S Canas, Mark S Graham, Kerstin Klaser, Marc Modat, Benjamin Murray, Marc F Österdahl, Nathan J Cheetham, David Drew, Long Nguyen, Joan Capdeila Pujol, Christina Hu, Somesh Selvachandran, Lorenzo Polidori, Anna May, Jonathan Wolf, Andrew T Chan, Alexander Hammers, Emma Duncan, Tim D Spector, Sebastien Ourselin, Claire J Steves
medRxiv 2021.05.24.21257738; doi: https://doi.org/10.1101/2021.05.24.21257738
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose S Penfold, Jordi Merino, Carole H Sudre, Erika Molteni, Sarah Berry, Liane S Canas, Mark S Graham, Kerstin Klaser, Marc Modat, Benjamin Murray, Marc F Österdahl, Nathan J Cheetham, David Drew, Long Nguyen, Joan Capdeila Pujol, Christina Hu, Somesh Selvachandran, Lorenzo Polidori, Anna May, Jonathan Wolf, Andrew T Chan, Alexander Hammers, Emma Duncan, Tim D Spector, Sebastien Ourselin, Claire J Steves
medRxiv 2021.05.24.21257738; doi: https://doi.org/10.1101/2021.05.24.21257738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (157)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8542)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1741)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1235)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10274)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1668)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (111)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1760)
  • Public and Global Health (3831)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (318)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)